Answers are grounded in this paper and cite their sources.
In this case, a woman with refractory diffuse large-B-cell lymphoma had a CNS recurrence that responded completely to anti-CD19 CAR T-cell therapy. After biopsy of a subsequent skin recurrence, the lesions cleared in association with an expansion of the CAR T cells in the blood.
No takes yet. Share an insight, caveat, or question.
Abramson et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: